Hospital
Helen Newberry Joy Hospital
Helen Newberry Joy Hospital was paid $2.84M by Medicaid between Jan 2018 and Dec 2024, across 99 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoHELEN NEWBERRY JOY HOSPITAL
NEWBERRY, MI 49868
NEWBERRY, MI 49868
33aNPI1497742050assigned 09/29/2005
33bProvider typeCritical Access Hospital
28Total paid$2.84M
24GClaims106,270
24DCodes billed99
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#21 of 31
Median peer was paid$6.03M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,355 | $320K | |
| 2019 | 15,800 | $324K | |
| 2020 | 14,041 | $388K | |
| 2021 | 17,667 | $515K | |
| 2022 | 16,928 | $496K | |
| 2023 | 13,931 | $425K | |
| 2024incomplete | 10,548 | $370K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 5,044 | 2,583 | $938K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 6,841 | 3,660 | $756K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.4% | 1,272 | 1,149 | $152K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.5% | 3,428 | 910 | $98K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.0% | 1,725 | 1,329 | $85K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.8% | 717 | 450 | $80K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 247 | 185 | $66K |
| 71046 | Radiologic examination, chest; 2 views | 2.2% | 1,363 | 1,277 | $62K |
| 80061 | Lipid panel | 1.4% | 2,645 | 2,638 | $39K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.3% | 1,584 | 1,412 | $37K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 534 | 362 | $36K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.2% | 190 | 187 | $35K |
87 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.2% | 984 | $33K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 1,886 | $33K |
| 80053 | Comprehensive metabolic panel | 1.1% | 8,406 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,366 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,583 | $25K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,261 | $24K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 225 | $23K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 176 | $22K |
| 71045 | Radiologic examination, chest; single view | <1% | 343 | $20K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 52 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,989 | $19K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,090 | $18K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 128 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 234 | $15K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 521 | $11K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,154 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 364 | $10K |
| 87430 | <1% | 1,092 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,615 | $9K |
| 80306 | <1% | 833 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $5K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $5K |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 14 | $4K |
| 87088 | <1% | 1,157 | $4K | |
| 85027 | <1% | 1,265 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 222 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 938 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 489 | $3K |
| 83735 | <1% | 2,380 | $2K | |
| 81025 | <1% | 1,169 | $2K | |
| 84439 | <1% | 438 | $2K | |
| 87070 | <1% | 503 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 128 | $2K |
| 81003 | <1% | 2,944 | $2K | |
| 87077 | <1% | 496 | $2K | |
| 85610 | <1% | 2,317 | $2K | |
| 87503 | <1% | 236 | $2K | |
| 82728 | <1% | 234 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 86 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 802 | $2K |
| 87186 | <1% | 293 | $1K | |
| 86140 | <1% | 1,683 | $987.60 | |
| 73630 | <1% | 45 | $980.10 | |
| 97161 | <1% | 25 | $962.21 | |
| 83880 | <1% | 292 | $951.69 | |
| 81001 | <1% | 1,191 | $944.10 | |
| 82607 | <1% | 103 | $796.61 | |
| 83690 | <1% | 1,351 | $753.95 | |
| 73564 | <1% | 14 | $697.43 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $648.44 |
| 73030 | <1% | 14 | $520.32 | |
| 84145 | <1% | 819 | $493.58 | |
| 85730 | <1% | 1,224 | $349.29 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 16 | $338.52 |
| 73130 | <1% | 12 | $262.04 | |
| 82150 | <1% | 768 | $221.02 | |
| 82550 | <1% | 720 | $203.03 | |
| 86803 | <1% | 25 | $195.62 | |
| 83605 | <1% | 976 | $191.01 | |
| 82746 | <1% | 25 | $179.87 | |
| 84484 | <1% | 1,067 | $137.41 | |
| 87210 | <1% | 30 | $116.04 | |
| 84481 | <1% | 12 | $114.66 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,106 | $108.76 |
| 85651 | <1% | 52 | $95.62 | |
| 85379 | <1% | 159 | $93.93 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $87.91 |
| 87807 | <1% | 21 | $72.62 | |
| 87340 | <1% | 12 | $57.19 | |
| 82248 | <1% | 20 | $47.25 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 71 | $34.58 |
| 86308 | <1% | 12 | $29.25 | |
| 82270 | <1% | 13 | $28.99 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,918 | $12.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,024 | $8.75 |
| 87040 | <1% | 15 | $6.48 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 121 | $5.06 |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | <1% | 13 | $0.03 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 905 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 108 | $0.00 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 0% | 12 | $0.00 |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 12 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 107 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 54 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 12 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 17 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEMERY-SHEA, EMILY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Helen Newberry Joy Hospital | Newberry, MI | $2.51M |
| Helen Newberry Joy Hospital | Curtis, MI | $143K |
| Helen Newberry Joy Hospital | Engadine, MI | $75K |
| Helen Newberry Joy Hospital | Eckerman, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.